Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug approved in Canada for treating Attention-Deficit/Hyperactivity Dysfunction in children and people. The medication functions as a prodrug, meaning https://vyvanse-pharmacy-in-cana470722.blogolize.com/vyvanse-in-canada-a-detailed-overview-82760553